Child sex abuser dies of cancer BBC News Tue, 29 Dec 2009 05:47 AM PST A man jailed for raping a teenage girl and for arson dies of cancer less than two years into a 12-year sentence. | Wake Tuesday for NYC firefighter, 48, Ground Zero worker Middletown Times Herald-Record Tue, 29 Dec 2009 05:23 AM PST NEW YORK (AP) -- A wake is being held for a New York City firefighter who worked at Ground Zero for six months after 9/11 and was later diagnosed with pancreatic cancer. | Hispanics, blacks wait longer on melanoma | By Landon Hall The Orange County Register The Longmont Times-Call Tue, 29 Dec 2009 05:16 AM PST Whites are surviving melanoma at much higher rates than decades ago, thanks to public awareness and early treatment. The trend hasnât extended to blacks and Hispanics, however: Those groups develop skin cancer much less frequently but tend to have more advanced progression at diagnosis, according to a new study. | Manchester resident running half marathon for cause The Manchester Enterprise Tue, 29 Dec 2009 05:12 AM PST An estimated 139,860 people in the United States were diagnosed with leukemia, lymphoma or myeloma in 2009 alone. That amounts to roughly one person every four minutes being diagnosed with a blood cancer. | New research could advance research field critical to personalized medicine PhysOrg Tue, 29 Dec 2009 04:57 AM PST It's the ultimate goal in the treatment of cancer: tailoring a person's therapy based on his or her genetic makeup. While a lofty goal, scientists are steadily moving forward, rapidly exploiting new technologies. Researchers at Georgetown Lombardi Comprehensive Cancer Center report a significant advance in this field of research using a new chip that looks for hundreds of mutations in dozen of ... | Affomix to generate antibodies against proprietary targets chosen by Kalgene News-Medical-Net Tue, 29 Dec 2009 04:51 AM PST Affomix Corporation, a pioneer in the development of automated, high-throughput monoclonal antibody selection technology, announced today that Kalgene Pharmaceuticals Inc. has signed a commercial agreement to have Affomix utilize its Y2HExpress⢠technology to select antibodies with potential diagnostic and therapeutic utility in breast cancer. Kalgene Pharmaceuticals Inc. is a private company ... | | |
|
No comments:
Post a Comment